| Literature DB >> 26033854 |
Giulia Magnabosco1, Matteo Di Giosia1, Iryna Polishchuk2, Eva Weber2, Simona Fermani1, Andrea Bottoni1, Francesco Zerbetto1, Pier Giuseppe Pelicci3, Boaz Pokroy2, Stefania Rapino1, Giuseppe Falini1, Matteo Calvaresi1.
Abstract
Doxorubicin (DOX)/CaCO3 single crystals act as pH responsive drug carrier. A biomimetic approach demonstrates that calcite single crystals are able, during their growth in the presence of doxorubicin, to entrap drug molecules inside their lattice along specific crystallographic directions. Alterations in lattice dimensions and microstructural parameters are determined by means of high-resolution synchrotron powder diffraction measurements. Confocal microscopy confirms that doxorubicin is uniformly embedded in the crystal and is not simply adsorbed on the crystal surface. A slow release of DOX was obtained preferentially in the proximity of the crystals, targeting cancer cells.Entities:
Keywords: calcium carbonate; doxorubicin; drug carriers; high-resolution synchrotron powder diffraction; intracrystalline
Mesh:
Substances:
Year: 2015 PMID: 26033854 DOI: 10.1002/adhm.201500170
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933